National Institute of Standards and Technology funding includes $83 million for coronavirus
Part of UD’s STAR Campus, the facility will be a center for research on producing complex medication
Kelvin Lee receives Marvin J. Johnson Award in Microbial and Biochemical Technology
UD ingenuity sheds light on key biopharmaceutical manufacturing problem
Biopharmaceuticals have emerged recently and are having a revolutionary impact on vexing diseases such as cancer. The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), headquartered at the University of Delaware, is at the forefront of making medicines more accessible to Americans.